1-14 of 14
Authors: Claudio Borghi
Save search
Sort by
Journal Article
EDITOR'S CHOICE

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024

PDF
Juan Tamargo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 292–317, https://doi.org/10.1093/ehjcvp/pvaf012
Published: 08 March 2025
Journal Article

Management of dyslipidaemia in patients with comorbidities—facing the challenge: Value and limitations of lipid-lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liver

PDF
Lisa Frühwald and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 2, March 2025, Pages 164–173, https://doi.org/10.1093/ehjcvp/pvae095
Published: 24 December 2024
Journal Article

Estimated impact of guidelines-based initiation of dual antihypertensive therapy on long-term cardiovascular outcomes in 1.1 million individuals

PDF
Antonio Coca and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 8, December 2024, Pages 697–707, https://doi.org/10.1093/ehjcvp/pvae048
Published: 09 July 2024
Journal Article

Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis

PDF
Paul M Haller and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 5, August 2024, Pages 444–453, https://doi.org/10.1093/ehjcvp/pvae042
Published: 06 June 2024
Journal Article
EDITOR'S CHOICE

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023

PDF
Juan Tamargo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 3, April 2024, Pages 219–244, https://doi.org/10.1093/ehjcvp/pvae013
Published: 20 February 2024
Journal Article

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022

PDF
Juan Tamargo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 4, June 2023, Pages 353–370, https://doi.org/10.1093/ehjcvp/pvad034
Published: 11 May 2023
Journal Article

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

PDF
Juan Tamargo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 4, July 2022, Pages 406–419, https://doi.org/10.1093/ehjcvp/pvac005
Published: 29 January 2022
Journal Article
EDITOR'S CHOICE

Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

PDF
Maria Lukács Krogager and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 6, November 2021, Pages 557–567, https://doi.org/10.1093/ehjcvp/pvab038
Published: 06 May 2021
Journal Article
EDITOR'S CHOICE

Renal protection in chronic heart failure: focus on sacubitril/valsartan

PDF
Roberto Pontremoli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 5, September 2021, Pages 445–452, https://doi.org/10.1093/ehjcvp/pvab030
Published: 03 April 2021
Journal Article

Effects of intensive urate lowering therapy with febuxostat in comparison with allopurinol on pulse wave velocity in patients with gout and increased cardiovascular risk: the FORWARD study

PDF
Giovambattista Desideri and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 3, May 2022, Pages 236–242, https://doi.org/10.1093/ehjcvp/pvaa144
Published: 15 January 2021
Journal Article
EDITOR'S CHOICE

Management of pregnancy-related hypertensive disorders in patients infected with SARS CoV-2: pharmacological and clinical issues

PDF
Silvia Fogacci and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 4, July 2021, Pages 346–351, https://doi.org/10.1093/ehjcvp/pvaa105
Published: 10 September 2020
Journal Article
EDITOR'S CHOICE

Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension

PDF
Renata Cífková and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 6, November 2020, Pages 384–393, https://doi.org/10.1093/ehjcvp/pvz082
Published: 16 December 2019
Journal Article
EDITOR'S CHOICE

Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases

PDF
Gianluigi Savarese and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 2, March 2020, Pages 86–93, https://doi.org/10.1093/ehjcvp/pvz036
Published: 08 August 2019
Journal Article
EDITOR'S CHOICE

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

PDF
Patrick Sulzgruber and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 3, July 2019, Pages 171–180, https://doi.org/10.1093/ehjcvp/pvz016
Published: 23 May 2019